Commensal Lactobacillus Controls Immune Tolerance during Acute Liver Injury in Mice

Cell Reports

Volumn 21, Issue 5, 2017, Pages 1215-1226

  Nakamoto, Nobuhiro ^a   Amiya, Takeru ^a,b   Aoki, Ryo ^a,c   Taniki, Nobuhito ^a   Koda, Yuzo ^a,b   Miyamoto, Kentaro ^a,d   Teratani, Toshiaki ^a   Suzuki, Takahiro ^a   Chiba, Sayako ^a   Chu, Po Sung ^a   Hayashi, Atsushi ^a,d   Yamaguchi, Akihiro ^a   Shiba, Shunsuke ^a   Miyake, Rei ^a   Katayama, Tadashi ^a   Suda, Wataru ^a,e   Mikami, Yohei ^a   Kamada, Nobuhiko ^f   Ebinuma, Hirotoshi ^a   Saito, Hidetsugu ^g   Hattori, Masahira ^e,h   Kanai, Takanori ^a   more..

^a KEIO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b MITSUBISHI TANABE PHARMA CORPORATION   (Japan)

^c EZAKI GLICO CO LTD   (Japan)

^d Miyarisan Pharmaceutical Co   (Japan)

^e UNIVERSITY OF TOKYO   (Japan)

^f UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^g KEIO UNIVERSITY   (Japan)

^h WASEDA UNIVERSITY   (Japan)

Author keywords

acute liver injury; dendritic cell; dysbiosis; immune tolerance; innate lymphoid cell; interleukin 10; interleukin 22; microbiota

Indexed keywords

CONCANAVALIN A; INTERLEUKIN 10; INTERLEUKIN 22; TRANSFORMING GROWTH FACTOR BETA; ALANINE AMINOTRANSFERASE; GAMMA INTERFERON; HLA ANTIGEN CLASS 2; INTERLEUKIN DERIVATIVE; INTERLEUKIN-22; TOLL LIKE RECEPTOR 9;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; COMMENSAL; CONCANAVALIN A-INDUCED HEPATITIS; CONTROLLED STUDY; CYTOKINE PRODUCTION; DENDRITIC CELL; IMMUNOLOGICAL TOLERANCE; INTESTINE FLORA; INTESTINE MUCOSA; LACTOBACILLUS; LIVER INJURY; LYMPHOID CELL; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; ANIMAL; BLOOD; C57BL MOUSE; CYTOLOGY; IMMUNOLOGY; INNATE IMMUNITY; INTESTINE; LIVER; METABOLISM; MICROBIOLOGY; PATHOLOGY; PHYSIOLOGY; REGULATORY T LYMPHOCYTE; TOXIC HEPATITIS;

ALANINE TRANSAMINASE; ANIMALS; CHEMICAL AND DRUG INDUCED LIVER INJURY; DENDRITIC CELLS; GASTROINTESTINAL MICROBIOME; HISTOCOMPATIBILITY ANTIGENS CLASS II; IMMUNE TOLERANCE; IMMUNITY, INNATE; INTERFERON-GAMMA; INTERLEUKIN-10; INTERLEUKINS; INTESTINES; LACTOBACILLUS; LIVER; MALE; MICE; MICE, INBRED C57BL; T-LYMPHOCYTES, REGULATORY; TOLL-LIKE RECEPTOR 9; TRANSFORMING GROWTH FACTOR BETA;

EID: 85034815496     PISSN: None     EISSN: 22111247     Source Type: Journal    
DOI: 10.1016/j.celrep.2017.10.022     Document Type: Article

References (47)

1. Balmer, M.L., Slack, E., de Gottardi, A., Lawson, M.A., Hapfelmeier, S., Miele, L., Grieco, A., Van Vlierberghe, H., Fahrner, R., Patuto, N., et al. The liver may act as a firewall mediating mutualism between the host and its gut commensal microbiota. Sci. Transl. Med., 6, 2014, 237ra66.
2. Bamboat, Z.M., Ocuin, L.M., Balachandran, V.P., Obaid, H., Plitas, G., DeMatteo, R.P., Conventional DCs reduce liver ischemia/reperfusion injury in mice via IL-10 secretion. J. Clin. Invest. 120 (2010), 559–569.
3. Betrapally, N.S., Gillevet, P.M., Bajaj, J.S., Changes in the intestinal microbiome and alcoholic and nonalcoholic liver diseases: causes or effects?. Gastroenterology 150 (2016), 1745–1755.e3.
4. Boursier, J., Mueller, O., Barret, M., Machado, M., Fizanne, L., Araujo-Perez, F., Guy, C.D., Seed, P.C., Rawls, J.F., David, L.A., et al. The severity of nonalcoholic fatty liver disease is associated with gut dysbiosis and shift in the metabolic function of the gut microbiota. Hepatology 63 (2016), 764–775.
5. Chen, P., Stärkel, P., Turner, J.R., Ho, S.B., Schnabl, B., Dysbiosis-induced intestinal inflammation activates tumor necrosis factor receptor I and mediates alcoholic liver disease in mice. Hepatology 61 (2015), 883–894.
6. Crispe, I.N., The liver as a lymphoid organ. Annu. Rev. Immunol. 27 (2009), 147–163.
7. Dalal, S.R., Chang, E.B., The microbial basis of inflammatory bowel diseases. J. Clin. Invest. 124 (2014), 4190–4196.
8. Dong, Z., Wei, H., Sun, R., Tian, Z., The roles of innate immune cells in liver injury and regeneration. Cell. Mol. Immunol. 4 (2007), 241–252.
9. Erhardt, A., Biburger, M., Papadopoulos, T., Tiegs, G., IL-10, regulatory T cells, and Kupffer cells mediate tolerance in concanavalin A-induced liver injury in mice. Hepatology 45 (2007), 475–485.
10. Fullerton, J.N., Gilroy, D.W., Resolution of inflammation: a new therapeutic frontier. Nat. Rev. Drug Discov. 15 (2016), 551–567.
11. Garcia-Martinez, I., Santoro, N., Chen, Y., Hoque, R., Ouyang, X., Caprio, S., Shlomchik, M.J., Coffman, R.L., Candia, A., Mehal, W.Z., Hepatocyte mitochondrial DNA drives nonalcoholic steatohepatitis by activation of TLR9. J. Clin. Invest. 126 (2016), 859–864.
12. Gimeno Brias, S., Stack, G., Stacey, M.A., Redwood, A.J., Humphreys, I.R., The Role of IL-22 in Viral Infections: Paradigms and Paradoxes. Front. Immunol., 7, 2016, 211.
13. Hanash, A.M., Dudakov, J.A., Hua, G., O'Connor, M.H., Young, L.F., Singer, N.V., West, M.L., Jenq, R.R., Holland, A.M., Kappel, L.W., et al. Interleukin-22 protects intestinal stem cells from immune-mediated tissue damage and regulates sensitivity to graft versus host disease. Immunity 37 (2012), 339–350.
14. Imaeda, A.B., Watanabe, A., Sohail, M.A., Mahmood, S., Mohamadnejad, M., Sutterwala, F.S., Flavell, R.A., Mehal, W.Z., Acetaminophen-induced hepatotoxicity in mice is dependent on Tlr9 and the Nalp3 inflammasome. J. Clin. Invest. 119 (2009), 305–314.
15. Jenq, R.R., Ubeda, C., Taur, Y., Menezes, C.C., Khanin, R., Dudakov, J.A., Liu, C., West, M.L., Singer, N.V., Equinda, M.J., et al. Regulation of intestinal inflammation by microbiota following allogeneic bone marrow transplantation. J. Exp. Med. 209 (2012), 903–911.
16. Jones-Hall, Y.L., Kozik, A., Nakatsu, C., Ablation of tumor necrosis factor is associated with decreased inflammation and alterations of the microbiota in a mouse model of inflammatory bowel disease. PLoS ONE, 10, 2015, e0119441.
17. Kamada, N., Seo, S.U., Chen, G.Y., Núñez, G., Role of the gut microbiota in immunity and inflammatory disease. Nat. Rev. Immunol. 13 (2013), 321–335.
18. Kim, C.J., Nazli, A., Rojas, O.L., Chege, D., Alidina, Z., Huibner, S., Mujib, S., Benko, E., Kovacs, C., Shin, L.Y., et al. A role for mucosal IL-22 production and Th22 cells in HIV-associated mucosal immunopathogenesis. Mucosal Immunol. 5 (2012), 670–680.
19. Kummen, M., Hov, J.R., Response to ‘Faecal microbiota profiles as diagnostic biomarkers in primary sclerosing cholangitis’ by Rühlemann et al. Gut 66 (2016), 755–756.
20. Lamas, B., Richard, M.L., Leducq, V., Pham, H.P., Michel, M.L., Da Costa, G., Bridonneau, C., Jegou, S., Hoffmann, T.W., Natividad, J.M., et al. CARD9 impacts colitis by altering gut microbiota metabolism of tryptophan into aryl hydrocarbon receptor ligands. Nat. Med. 22 (2016), 598–605.
21. Manichanh, C., Borruel, N., Casellas, F., Guarner, F., The gut microbiota in IBD. Nat. Rev. Gastroenterol. Hepatol. 9 (2012), 599–608.
22. Matsuoka, K., Kanai, T., The gut microbiota and inflammatory bowel disease. Semin. Immunopathol. 37 (2015), 47–55.
23. Mortha, A., Chudnovskiy, A., Hashimoto, D., Bogunovic, M., Spencer, S.P., Belkaid, Y., Merad, M., Microbiota-dependent crosstalk between macrophages and ILC3 promotes intestinal homeostasis. Science, 343, 2014, 1249288.
24. Mutlu, E.A., Gillevet, P.M., Rangwala, H., Sikaroodi, M., Naqvi, A., Engen, P.A., Kwasny, M., Lau, C.K., Keshavarzian, A., Colonic microbiome is altered in alcoholism. Am. J. Physiol. Gastrointest. Liver Physiol. 302 (2012), G966–G978.
25. Nakamoto, N., Kanai, T., Role of toll-like receptors in immune activation and tolerance in the liver. Front. Immunol., 5, 2014, 221.
26. Nakamoto, N., Ebinuma, H., Kanai, T., Chu, P.S., Ono, Y., Mikami, Y., Ojiro, K., Lipp, M., Love, P.E., Saito, H., Hibi, T., CCR9+ macrophages are required for acute liver inflammation in mouse models of hepatitis. Gastroenterology 142 (2012), 366–376.
27. Pasare, C., Medzhitov, R., Toll-like receptors: linking innate and adaptive immunity. Adv. Exp. Med. Biol. 560 (2005), 11–18.
28. Radaeva, S., Sun, R., Pan, H.N., Hong, F., Gao, B., Interleukin 22 (IL-22) plays a protective role in T cell-mediated murine hepatitis: IL-22 is a survival factor for hepatocytes via STAT3 activation. Hepatology 39 (2004), 1332–1342.
29. Robinson, M.W., Harmon, C., O'Farrelly, C., Liver immunology and its role in inflammation and homeostasis. Cell. Mol. Immunol. 13 (2016), 267–276.
30. Rothhammer, V., Mascanfroni, I.D., Bunse, L., Takenaka, M.C., Kenison, J.E., Mayo, L., Chao, C.C., Patel, B., Yan, R., Blain, M., et al. Type I interferons and microbial metabolites of tryptophan modulate astrocyte activity and central nervous system inflammation via the aryl hydrocarbon receptor. Nat. Med. 22 (2016), 586–597.
31. Sabino, J., Vieira-Silva, S., Machiels, K., Joossens, M., Falony, G., Ballet, V., Ferrante, M., Van Assche, G., Van der Merwe, S., Vermeire, S., Raes, J., Primary sclerosing cholangitis is characterised by intestinal dysbiosis independent from IBD. Gut 65 (2016), 1681–1689.
32. Sakamoto, T., Mabuchi, A., Kuriya, S., Sudo, T., Aida, T., Asano, G., Shoji, T., Yokomuro, K., Production of granulocyte-macrophage colony-stimulating factor by adult murine parenchymal liver cells (hepatocytes). Reg. Immunol. 3 (1990–1991), 260–267.
33. Sander, L.E., Sackett, S.D., Dierssen, U., Beraza, N., Linke, R.P., Müller, M., Blander, J.M., Tacke, F., Trautwein, C., Hepatic acute-phase proteins control innate immune responses during infection by promoting myeloid-derived suppressor cell function. J. Exp. Med. 207 (2010), 1453–1464.
34. Sonnenberg, G.F., Fouser, L.A., Artis, D., Border patrol: regulation of immunity, inflammation and tissue homeostasis at barrier surfaces by IL-22. Nat. Immunol. 12 (2011), 383–390.
35. Szabo, G., Petrasek, J., Inflammasome activation and function in liver disease. Nat. Rev. Gastroenterol. Hepatol. 12 (2015), 387–400.
36. Takeuchi, O., Akira, S., Pattern recognition receptors and inflammation. Cell 140 (2010), 805–820.
37. Taylor, C.T., Dzus, A.L., Colgan, S.P., Autocrine regulation of epithelial permeability by hypoxia: role for polarized release of tumor necrosis factor alpha. Gastroenterology 114 (1998), 657–668.
38. Thomson, A.W., Knolle, P.A., Antigen-presenting cell function in the tolerogenic liver environment. Nat. Rev. Immunol. 10 (2010), 753–766.
39. Tiegs, G., Lohse, A.W., Immune tolerance: what is unique about the liver. J. Autoimmun. 34 (2010), 1–6.
40. Tiegs, G., Hentschel, J., Wendel, A., A T cell-dependent experimental liver injury in mice inducible by concanavalin A. J. Clin. Invest. 90 (1992), 196–203.
41. Valladares, R., Bojilova, L., Potts, A.H., Cameron, E., Gardner, C., Lorca, G., Gonzalez, C.F., Lactobacillus johnsonii inhibits indoleamine 2,3-dioxygenase and alters tryptophan metabolite levels in BioBreeding rats. FASEB J. 27 (2013), 1711–1720.
42. Wolk, K., Kunz, S., Witte, E., Friedrich, M., Asadullah, K., Sabat, R., IL-22 increases the innate immunity of tissues. Immunity 21 (2004), 241–254.
43. Yan, A.W., Fouts, D.E., Brandl, J., Stärkel, P., Torralba, M., Schott, E., Tsukamoto, H., Nelson, K.E., Brenner, D.A., Schnabl, B., Enteric dysbiosis associated with a mouse model of alcoholic liver disease. Hepatology 53 (2011), 96–105.
44. Zelante, T., Iannitti, R.G., Cunha, C., De Luca, A., Giovannini, G., Pieraccini, G., Zecchi, R., D'Angelo, C., Massi-Benedetti, C., Fallarino, F., et al. Tryptophan catabolites from microbiota engage aryl hydrocarbon receptor and balance mucosal reactivity via interleukin-22. Immunity 39 (2013), 372–385.
45. Zenewicz, L.A., Yin, X., Wang, G., Elinav, E., Hao, L., Zhao, L., Flavell, R.A., IL-22 deficiency alters colonic microbiota to be transmissible and colitogenic. J. Immunol. 190 (2013), 5306–5312.
46. Zhou, L., AHR function in lymphocytes: emerging concepts. Trends Immunol. 37 (2016), 17–31.
47. Zhu, L., Baker, S.S., Gill, C., Liu, W., Alkhouri, R., Baker, R.D., Gill, S.R., Characterization of gut microbiomes in nonalcoholic steatohepatitis (NASH) patients: a connection between endogenous alcohol and NASH. Hepatology 57 (2013), 601–609.